Search

Your search keyword '"Mantini G"' showing total 502 results

Search Constraints

Start Over You searched for: Author "Mantini G" Remove constraint Author: "Mantini G"
502 results on '"Mantini G"'

Search Results

5. How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study

7. Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study)

8. Detection and localization of early- and late-stage cancers using platelet RNA

9. Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR)

11. Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR)

12. Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study)

13. EP-1325 Personalized Medicine in breast cancer: a nomogram from prognostic score to deescalate radiotherapy

14. Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study)

16. Impact of Gastrointestinal Side Effects on Patients’ Reported Quality of Life Trajectories after Radiotherapy for Prostate Cancer: Data from the Prospective, Observational Pros-IT CNR Study

20. Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study

21. BIT-ART: Multicentric comparison of HDR-brachytherapy, intensity-modulated radiotherapy and tomotherapy for advanced radiotherapy in prostate cancer

22. Simultaneous integrated radiotherapy boost to the dominant intraprostatic lesion: Final results of a phase I/II trial

23. Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis

24. Early results from a phase II randomized trial testing stereotactic body radiation therapy in patients with oligometastatic castration resistant prostate cancer undergoing I line treatment with abiraterone acetate (ARTO trial-NCT03449719)

25. The biology of regulatory pathways of miRNAs, mRNAs and proteins unravels a specific -omics network in tumor-educated platelets from pancreatic cancer patients

26. PO-1185: Results of prostate cancer patients treated by integrated boost to dominant intraprostatic lesion

27. Blood platelet RNA yields a new diagnostic prospective for accurate detection and staging of pancreatic ductal adenocarcinoma

33. OncotypeDX (R) predictive nomogram for recurrence score output: A machine learning system based on quantitative immunochemistry analysis-ADAPTED01

34. Percutaneous radiofrequency ablation using internally cooled wet electrodes for the treatment of patients with lung tumors

35. Radiotherapy plus GnRH analogue versus high dose bicalutamide: A case control study

37. Guidelines on prostate carcinoma - AIRO, 2016

38. OncotypeDX® predictive nomogram for recurrence score output: A machine learning system based on quantitative immunochemistry analysis - ADAPTED01

39. EP-1928 Radiomic features and local response in Lung Cancer treated with Stereotactic Radiation Therapy

41. EP-1325 Personalized Medicine in breast cancer: a nomogram from prognostic score to deescalate radiotherapy

42. Edema or Margin in Glioblastoma CTV? Impact on Pattern of Recurrence and Survival of Two Different CTV Delineations Independently Peer Reviewed

43. Guidelines on prostate carcinoma - AIRO, 2016

44. Tailored postoperative treatment of prostate cancer: final results of a phase I/II trial

46. EP-1399: HEmatologic paRaMeters as prEdictive biomarkerS in NSCLC (HERMES-Lung) for metastasis development

47. P040 - Early results from a phase II randomized trial testing stereotactic body radiation therapy in patients with oligometastatic castration resistant prostate cancer undergoing I line treatment with abiraterone acetate (ARTO trial-NCT03449719)

48. PRODIGE: PRediction models in prOstate cancer for personalized meDIcine challenGE

49. The predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: Low-dose fractionated radiotherapy with concurrent chemotherapy

50. PRODIGE: PRediction models in prOstate cancer for personalized meDIcine challenGE

Catalog

Books, media, physical & digital resources